ANPD001 eases motor symptoms, early trial data show
The first three Parkinson's patients who received ANPD001 saw improvements in motor symptoms and daily functioning, early trial data showed.| Parkinson's News Today
The first three Parkinson's patients who received ANPD001 saw improvements in motor symptoms and daily functioning, early trial data showed.| Parkinson's News Today
A recent study confirmed columnist Mollie Lombardi's observations about the different ways women and men approach DBS surgery for Parkinson's.| Parkinson's News Today
In the first of a four-part series on deep brain stimulation for Parkinson's, columnist Mollie Lombardi describes her initial DBS surgery.| Parkinson's News Today
A sweet story has a cringeworthy ending for columnist Christine Scheer, who lost her sense of smell and taste because of Parkinson's.| Parkinson's News Today
Target enrollment is complete for a Phase 1b trial testing the safety and tolerability of GT-02287 in people with Parkinson’s disease.| Parkinson's News Today
Living within three miles of a golf course may increase the risk of Parkinson’s disease, possibly due to pesticide exposure, per a study.| Parkinson's News Today
Columnist Doc Irish pays tribute to his dog, Jax, in a reflection on aging that also looks at his own life with Parkinson's disease.| Parkinson's News Today
People with Parkinson's can have trouble identifying emotions, an idea that has columnist Mary Beth Skylis looking at her father anew.| Parkinson's News Today
Metabolic syndrome is associated with an increased risk of dementia among people with Parkinson's disease, according to a study from Turkey.| Parkinson's News Today
Most people with Parkinson's disease don't experience dementia in the first decade after diagnosis, a study found.| Parkinson's News Today
In her debut, columnist Mollie Lombardi describes her early collection of symptoms and how she discovered what they meant: Parkinson's.| Parkinson's News Today
In his debut column, Chukwuemeka Uchebuakor describes the importance of the "love factor" in caring for his father with Parkinson's.| Parkinson's News Today
Medical scientists recognize two types of Parkinson's disease: primary parkinsonism and forms known as atypical and secondary parkinsonism.| Parkinson's News Today
Microglia-driven inflammation plays key role in Parkinson’s disease development by contributing to the spread of abnormal clumps, per a study.| Parkinson's News Today
Blocking the stress sensor GADD45G in astrocytes — star-shaped cells that support neurons — may be a therapeutic strategy for Parkinson’s.| Parkinson's News Today
The FDA has cleared CAP-003, a gene therapy for Parkinson’s associated with GBA mutations, to be tested in clinical trials.| Parkinson's News Today
Parkinson's patients in a pilot study at Texas A&M say they enjoy equine-assisted therapy, and researchers hope to prove it's effective.| Parkinson's News Today
Stimulating a region of the brain involved in processing sound may help ease motor symptoms in Parkinson’s disease, a rat study found.| Parkinson's News Today
Casma Therapeutics will develop CSM-101 as a potential oral treatment for Parkinson's disease and Gaucher disease.| Parkinson's News Today
Cure Parkinson’s is funding SLEIPNIR, a clinical trial platform that will simultaneously test up to three disease-modifying treatments.| Parkinson's News Today
Routine evaluations and adjustments provide columnist Mollie Lombardi the best results with her deep brain stimulator.| Parkinson's News Today
Sleep disorders were mainly associated with Parkinson's motor symptoms and problems regulating involuntary bodily functions, a s tudy shows.| Parkinson's News Today
Michael S. Okun, MD, answers questions about deep brain stimulation for people with Parkinson's in our monthly "Expert Voices" series.| Parkinson's News Today
Blood levels of 2 proteins in REM sleep behavior disorder patients linked with later finding of Parkinson's-like disease, Lewy body dementia.| Parkinson's News Today
Columnist Mollie Lombardi hopes she doesn't experience the Parkinson's dementia that her grandpa had to endure.| Parkinson's News Today
Read about physiotherapy and exercise programs, done under a specialist's guidance, to help maintain muscle strength and balance in Parkinson's patients.| Parkinson's News Today
Side-to-side eye movements reduced body sway in people with Parkinson's disease in a study of 10 people with Parkinson's and 11 without it.| Parkinson's News Today
Insightec's Exablate Neuro device is approved by the FDA for use by some Parkinson's patients with moderate-to-severe motor complications.| Parkinson's News Today
In a trial, once-daily buntanetap halted cognitive decline in early-stage Parkinson's and improved cognition in patients with mild dementia.| Parkinson's News Today
Parkinson’s patients show an inflammatory gut microbiome (bacterial population of the intestines) regardless of disease status or lifestyle.| Parkinson's News Today
Poor hand grip strength was tied to a higher risk of developing Parkinson’s in a U.K. study, especially among those with genetic risk factors.| Parkinson's News Today
Non-motor symptoms, ranging from depression to constipation, problems sleeping to cognitive changes, can be fairly common in Parkinson's.| Parkinson's News Today
Most Parkinson's patients experience a range of walking difficulties, resulting in distinctive gait and balance problems.| Parkinson's News Today
US neurologists are optimistic about the potential for a new Huntington's disease treatment - preferably a gene therapy - per a market survey.| Huntington's Disease News
Columnist Mollie Lombardi shares how her early-onset Parkinson's disease diagnosis has affected her husband and their marriage.| Parkinson's News Today
Certain rare genetic variants tied to Parkinson’s and other diseases raise the risk of developing ALS by more than three times, per a study.| ALS News Today
A brain surgery called corpus callosotomy reduced seizure burden in a young girl with Rett syndrome and hard-to-treat seizures, per a report.| Rett Syndrome News
Buntanetap lowered amyloid-beta and tau levels in people with early Alzheimer's disease and its developer Annovis Bio is planning more trials.| Alzheimer's News Today
When choosing members of your healthcare team, don't settle for just "OK," says columnist Christine Scheer. Advocating for yourself is key.| Parkinson's News Today
Focused ultrasound, a minimally invasive technology, will soon be available at Vanderbilt to treat essential tremor and Parkinson’s disease.| Parkinson's News Today
Columnist Christine Scheer compares her Parkinson's symptoms today with their severity before she had deep brain stimulation surgery.| Parkinson's News Today
While there's no test to confirm a Parkinson's diagnosis in its early stages, the disease can be detected based on a variety of symptoms.| Parkinson's News Today
Columnist Mary Beth Skylis shares tips for positive coping skills that she encourages her dad, who has Parkinson's, to implement.| Parkinson's News Today
The Parkinson's Progression Markers Initiative, launched in 2010 to better understand and treat the disease, will recruit at sites in Canada.| Parkinson's News Today
Parkinson's disease symptoms affect both motor skills and nonmotor skills, and progress differently in each person.| Parkinson's News Today
The gut microbiome of Parkinson's patients shows substantial functional differences compared with that of healthy people, per a new study.| Parkinson's News Today
The motor symptoms of Parkinson’s disease refer to those that affect the body’s movement and are grouped into primary and secondary motor symptoms.| Parkinson's News Today
The causes of Parkinson's disease can include a combination of genetic and environmental factors. Age and gender may also be risk factors.| Parkinson's News Today
The American Parkinson Disease Association (APDA) has awarded $2.6 million to research projects aiming to better understand Parkinson's.| Parkinson's News Today
The FDA approved a brain mapping tool that will enable doctors to more precisely use neuromodulation therapies like DBS.| Parkinson's News Today
A history of upper gastrointestinal mucosal damage was associated with a 76% greater risk of subsequently developing Parkinson's disease.| Parkinson's News Today
The first patient has been dosed in a Phase 2a trial of Parkinson's therapy VTX3232, an oral medication designed to reduce inflammation.| Parkinson's News Today
The FDA issued a letter encouraging the use of an alpha-synuclein assay to improve the efficiency of clinical trials in Parkinson's disease.| Parkinson's News Today
Regeneron joined the data syndication program for the LEARNS study that's assessing digital biomarkers for measuring Parkinson's progression.| Parkinson's News Today
UCF researchers have developed a biosensor that can rapidly detect and quantify dopamine levels in unprocessed blood samples.| Parkinson's News Today
Understanding and identifying epigenetic changes in blood samples from people with Parkinson’s disease may help assess the risk of dementia.| Parkinson's News Today
The clinical trial is assessing the safety of Allyx Therapeutics' ALX-001 versus a placebo when given to adults twice daily for 28 days.| Parkinson's News Today
An ALS diagnosis requires testing for signs of the neurodegenerative disease that rules out other disorders with similar symptoms.| ALS News Today
Ingrezza is an oral medication approved in the U.S. for chorea, or the involuntary, jerky movements that characterize Huntington’s disease.| Huntington's Disease News
Starting treatment with PrimeC six months sooner was associated with slower disease progression and a survival benefit for ALS patients.| ALS News Today
CNM-Au8 is an experimental liquid treatment for people with ALS that intends to increase cell energy.| ALS News Today
Anavex is preparing meetings with regulatory authorities in the U.S., Europe, and Asia-Pacific to discuss Anavex 2-73’s potential approval.| Alzheimer's News Today
Experimental blarcamesine (Anavex 2-73) was able to slow cognitive and functional decline in early Alzheimer’s patients over a year, data show.| Alzheimer's News Today
Buntanetap, a small molecule from Annovis Bio, improved cognitive function in people with mild Alzheimer’s with certain biomarkers.| Alzheimer's News Today
MS is an autoimmune disease that affects the central nervous system. Learn more about MS types, causes, symptoms, diagnosis, and treatment.| Multiple Sclerosis News Today
